Warning letter
InnoMark, Inc.: warning letter of Sep 1, 2023
FDA warning letter 657518 · Division of Human and Animal Food Operations West IV
Key facts
| Reference number | 657518 |
|---|---|
| Company | InnoMark, Inc. |
| Subject | CGMP/Dietary Supplement/Misbranded |
| Issue date | Sep 1, 2023 |
| Posted date | Nov 7, 2023 |
| Issuing office | Division of Human and Animal Food Operations West IV |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.4, 101.36, 111, 111.73, 111.75, 111.95, 111.105, 111.210, 101.2(e), 101.36(b)(3)(iv), 101.9(b), 111.70(b)(2) and 40 more |
| Inspection city | Saint George |
| Inspection ZIP | 84790 |
| Inspection start date | Mar 8, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: